PMID: 9428619Jan 15, 1998Paper

Polymorphism of the angiotensin-converting enzyme gene and cardiovascular disease

Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte
H Schunkert

Abstract

The angiotensin-converting enzyme (ACE) is an integral part of two enzymatic cascades, one leading to the generation of angiotensin II and the other to the degradation of bradykinin. The great variety of cardiovascular effects mediated by these vasoactive peptides and the efficacy of ACE inhibitors in the treatment of hypertension and heart failure emphasize the prominent role of ACE in the cardiovascular system. Early in this decade convincing experimental evidence demonstrated the induction of this enzyme in several pathophysiological conditions, including myocardial infarction and left ventricular hypertrophy. In parallel, a deletion/insertion (D/I) polymorphism of the human ACE gene was characterized that is related to 14-50% of the interindividual variance in serum ACE activity. More recently this polymorphism has been implicated in the pathogenesis of a variety of cardiovascular disorders, including myocardial infarction, left ventricular hypertrophy, hypertension, diabetic and IgA nephropathy, carotid artery thickening, and lacunar cerebral stroke. However, the associations between the ACE D/I polymorphism and most of these conditions were found to be inconsistent when additional populations were investigated. This contr...Continue Reading

Citations

Jan 13, 2004·Journal of Applied Physiology·Steve D McColeJames M Hagberg
Nov 16, 2004·Journal of Clinical Laboratory Analysis·Tatsuya SakumaMario H Hirata
May 27, 2014·BioMed Research International·Kh Dhanachandra SinghMuthusamy Karthikeyan
May 23, 2002·Journal of the American Animal Hospital Association·Mark A Oyama, William P Thomas
Jan 11, 2000·Circulation Research·C H GelbandM K Raizada
May 13, 1999·Nature Genetics·M J RiederD A Nickerson
Jan 18, 2003·Current Hypertension Reports·Xiaofeng Zhu, Richard S Cooper
Oct 24, 2002·Critical Care Medicine·Gere Sunder-PlassmannManuela Födinger
Aug 14, 2003·Human Molecular Genetics·Donna G Albertson, Daniel Pinkel
Oct 7, 2003·American Journal of Physiology. Heart and Circulatory Physiology·María Paz OcaranzaSergio Lavandero
May 18, 2006·Acta Ophthalmologica Scandinavica·Elke SchäferAnton Haas
Mar 14, 2000·Herz·B Mayer, H Schunkert
Nov 6, 1998·Journal of Applied Physiology·J M HagbergG E Moore
Feb 14, 2002·Journal of Applied Physiology·James M HagbergGeoffrey E Moore
May 8, 2003·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Chihiro TanakaToshiyuki Miyata
Sep 22, 2007·Current Heart Failure Reports·Eric M SnyderBruce D Johnson
May 31, 2017·Herz·J A Wermelt, H Schunkert
Nov 10, 2001·Annual Review of Genomics and Human Genetics·R L NicolE N Olson
Nov 11, 1999·Current Opinion in Lipidology·J P O'MalleyD R Illingworth
Mar 29, 2003·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Hiroyuki SuminoMasahiko Kurabayashi
May 21, 2005·Asian Cardiovascular & Thoracic Annals·Kanat OzisikFehmi Katircioglu
Jun 26, 2001·European Journal of Clinical Investigation·M CarluccioR De Caterina
Jan 13, 2021·Herz·Katharina Lechner, Heribert Schunkert
Nov 6, 2001·The American Journal of Cardiology·V J DzauUNKNOWN Working Group on Tissue Angiotensin-converting enzyme, International Society of Cardiovascular Pharmacotherapy
Jun 6, 2003·Brain Research Bulletin·A RocchiL Murri
Aug 18, 2005·Kidney International·Veena RaizadaCharles T Spalding
Sep 23, 2000·American Journal of Human Genetics·X ZhuM J Rieder
May 19, 2021·Pharmacogenetics and Genomics·Birte MöhlendickAndreas Kribben

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.